Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 4/20 | 0.34 |
| ▸ | MEN1 | O00255 | 4/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | APAF1 | O14727 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.34 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | HK1 | P19367 | 1/20 | 0.34 |
| ▸ | GALK1 | P51570 | 1/20 | 0.34 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29349590 | 1.00 | IDO1 (0.40) | IDO1CYP1A2CYP2D6MAPTMEN1 | |
| SCHEMBL21541520 | 0.87 | IDO1 (0.36) | IDO1CYP1A2CYP2D6MAPTMEN1 | |
| SCHEMBL29427705 | 0.82 | HRH4 (0.44) | CYP1A2MAPTMEN1KMT2AKDM4E | |
| SCHEMBL844612 | 0.80 | IDO1 (0.30) | IDO1 | |
| SCHEMBL31738437 | 0.79 | TDP1 (0.37) | CYP1A2CYP2D6MAPTMEN1KMT2A | |
| SCHEMBL11171665 | 0.79 | IDO1 (0.34) | IDO1CYP1A2CYP2D6MAPTMEN1 | |
| SCHEMBL31404223 | 0.79 | CDK5 (0.35) | IDO1MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL32691813 | 0.78 | — | — | |
| SCHEMBL241482 | 0.77 | ABCG2 (0.35) | IDO1 | |
| SCHEMBL31571479 | 0.77 | ABCG2 (0.35) | IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220263028-A1 | CONDENSED CYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-08-18 | — | — | US | claimed |
| EP-1919979-B2 | POLYMER CONJUGATES OF K-252A AND DERIVATIVES THEREOF | CREABILIS THERAPEUTICS SPA (IT) | 2017-03-29 | — | — | EP | claimed |
| US-20100292209-A1 | METHODS FOR IDENTIFYING COMPOUNDS THAT MODULATE NEUROTROPHIC FACTOR SIGNALING | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2010-11-18 | — | — | US | claimed |
| WO-2008121346-A1 | METHODS FOR IDENTIFYING COMPOUNDS THAT MODULATE NEUROTROPHIC FACTOR SIGNALING | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2008-10-09 | — | — | WO | claimed |
| EP-1919979-A1 | POLYMER CONJUGATES OF K-252A AND DERIVATIVES THEREOF | Creabilis Therapeutics S.P.A. (IT) | 2008-05-14 | — | — | EP | claimed |
| WO-2007022999-A1 | POLYMER CONJUGATES OF K-252A AND DERIVATIVES THEREOF | CREABILIS THERAPEUTICS S.P.A. (IT) | 2007-03-01 | — | — | WO | claimed |
| US-20260136750-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME AND COMPOSITION FOR FORMING ORGANIC MATERIAL LAYER OF ORGANIC LIGHT EMITTING DEVICE | LT MATERIALS CO LTD (KR) | 2026-05-14 | — | — | US | disclosed |
| US-20260096342-A1 | HETEROCYCLIC COMPOUND, COMPOSITION FOR ORGANIC LAYER INCLUDING THE SAME AND LIGHT EMITTING DEVICE INCLUDING THE SAME | LT MATERIALS CO LTD (KR) | 2026-04-02 | — | — | US | disclosed |
| US-20260090188-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT EMITTING DEVICE | LT MATERIALS CO LTD (KR) | 2026-03-26 | — | — | US | disclosed |
| US-20260076027-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO LTD (KR) | 2026-03-12 | — | — | US | disclosed |
| EP-4707356-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | LT Materials Co., Ltd. (KR) | 2026-03-11 | — | — | EP | disclosed |
| US-20260026190-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | LT MATERIALS CO LTD (KR) | 2026-01-22 | — | — | US | disclosed |
| EP-4682150-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | LT Materials Co., Ltd. (KR) | 2026-01-21 | — | — | EP | disclosed |
| WO-2000064917-A2 | SYNTHETIC INDOLOCARBAZOLE REGIOISOMERS AND USES THEREOF | ADVANCED LIFE SCIENCES INC. (US) | 2000-11-02 | — | — | WO | disclosed |
| EP-0971717-A4 | CYTOTOXIC AMINO SUGAR AND RELATED SUGAR DERIVATIVES OF INDOLOPYRROLOCARBAZOLES | BRISTOL MYERS SQUIBB CO (US) | 2000-04-12 | — | — | EP | disclosed |
| EP-0971717-A1 | CYTOTOXIC AMINO SUGAR AND RELATED SUGAR DERIVATIVES OF INDOLOPYRROLOCARBAZOLES | Bristol-Myers Squibb Company (US) | 2000-01-19 | — | — | EP | disclosed |
| WO-2000001699-A1 | NOVEL INDOLOCARBAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES AND CANCER | BAYER AKTIENGESELLSCHAFT (DE) | 2000-01-13 | — | — | WO | disclosed |
| US-6013646-A | ALZHEIMER'S DISEASE | BAYER CORPORATION (US) | 2000-01-11 | — | — | US | disclosed |
| WO-1998007433-A1 | CYTOTOXIC AMINO SUGAR AND RELATED SUGAR DERIVATIVES OF INDOLOPYRROLOCARBAZOLES | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-02-26 | — | — | WO | disclosed |
| WO-1997007081-A2 | GLYCOSYLATED INDOLOCARBAZOLE SYNTHESIS | YALE UNIVERSITY (US) | 1997-02-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260026190-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | LBR, CBR1, CRY1 | IDO1 1118/4885CYP1A2 460/4885CYP2D6 733/4885 |
| US-20260076027-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | CRY1, CYC1, CRY2 | IDO1 709/4885CYP1A2 58/4885CYP2D6 117/4885 |
| US-20260136750-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME AND COMPOSITION FOR FORMING ORGANIC MATERIAL LAYER OF ORGANIC LIGHT EMITTING DEVICE | CCNL2, CRY1, CRY2 | IDO1 944/4885CYP1A2 85/4885CYP2D6 799/4885 |
| US-20260090188-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT EMITTING DEVICE | CRY2, CRY1, SCO2 | IDO1 1520/4885CYP1A2 114/4885CYP2D6 750/4885 |
| US-20260096342-A1 | HETEROCYCLIC COMPOUND, COMPOSITION FOR ORGANIC LAYER INCLUDING THE SAME AND LIGHT EMITTING DEVICE INCLUDING THE SAME | CBR1, HCRTR2, GLRA1 | IDO1 1339/4885CYP1A2 591/4885CYP2D6 1459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.